| Literature DB >> 35216107 |
Emanuela Paduraru1, Diana Iacob1, Viorica Rarinca1, Angelica Rusu1, Roxana Jijie2, Ovidiu-Dumitru Ilie3, Alin Ciobica3,4,5, Mircea Nicoara3, Bogdan Doroftei6.
Abstract
Mercury (Hg) is considered one of the most widespread toxic environmental pollutants, which seems to have multiple effects on organisms even at low concentrations. It has a critical role in many health problems with harmful consequences, with Hg primarily targeting the brain and its components, such as the central nervous system (CNS). Hg exposure was associated with numerous CNS disorders that frequently trigger Alzheimer's disease (AD). Patients with AD have higher concentrations of Hg in blood and brain tissue. This paper aims to emphasize a correlation between Hg and AD based on the known literature in the occupational field. The outcome shows that all these concerning elements could get attributed to Hg. However, recent studies did not investigate the molecular level of Hg exposure in AD. The present review highlights the interactions between Hg and AD in neuronal degenerations, apoptosis, autophagy, oxidative stress (OS), mitochondrial malfunctions, gastrointestinal (GI) microflora, infertility and altering gene expression.Entities:
Keywords: Alzheimer’s disease; apoptosis; autophagy; fertility; gut microbiota; mercury poisoning; neurological toxicity; oxidative stress
Mesh:
Substances:
Year: 2022 PMID: 35216107 PMCID: PMC8879904 DOI: 10.3390/ijms23041992
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Symptoms associated with Hg poisoning of organ systems (data modified from Zahir et al. [3]).
Summary of some studies with neurological effects of Hg exposure.
| Exposure Duration | Age of Exposure | Species | Chemical | Concentration | Major Endpoints | Reference |
|---|---|---|---|---|---|---|
| 4–72 h | embryos | zebrafish | MeHg | 6 μg·L−1 | Impaired development of the fin fold and the tail fin primordium, alterations in transgene expression | [ |
| 6–96 h | embryos | zebrafish | MeHg | 5–1000 μg·L−1 | Delayed hatching, decreased cell proliferation rate within the neural tube, mortality | [ |
| 24 h | larvae | zebrafish | Mercury chloride (HgCl2) | 20 μg·L−1 | Decreased catalase (CAT) activity and increased malondialdehyde (MDA) levels | [ |
| 24 h | embryos | zebrafish | MeHg, HgCl2 | 100–1000 μg·L−1 | Delayed toxicity, | [ |
| 24 h | embryos | zebrafish | HgCl2 | 1 μM | [ | |
| 32 h | adults | zebrafish | HgCl2 | 1–15 μg·L−1 | Memory loss, aggression, low swimming performances, OS | [ |
| 96 h | adults | zebrafish | HgCl2 | 7.7–38.5 μg·L−1 | Degeneration, apoptosis | [ |
| 96 h | larvae | zebrafish | HgCl2 | 0–400 nM | A decreased survival rate, shrinking in body length and eye diameter, | [ |
| 7 days | embryos | zebrafish | HgCl2 | 1–16 μg·L−1 | Delayed hatching and | [ |
| 7−14 days | juvenile | White seabream | Hg2+ | 2 μg·L−1 | Optic tectum cells reduction | [ |
| 10 days | embryos | Medaka fish | Methyl mercury chloride (CH3HgCl) | 0.001–10 μM | Skeletal malformations, pericardial oedema | [ |
| 30 days | adults | Gilthead Seabream | MeHg | 10 μg·L−1 | OS | [ |
Summary of several studies used in this review to present the effects of Hg on rodents (g-grams).
| Exposure Duration | Age of Exposure | Species | Chemical | Concentration | Major Endpoints | Reference |
|---|---|---|---|---|---|---|
| 24 h | 56 days old | BALB/c | MeHg | 0–10,000 µg·kg−1 | Accumulation in brain | [ |
| 5 days (pre-gestational), 19 days (pregnancy) | Adult | Female Wistar rats | MeHg | 1000 µg·kg−1/day | Neuron loss in the brain, hippocampus and amygdala | [ |
| 11 days | 61–67 days old | Female Sprague-Dawley rats | Hg vapour Hg0 | 1; 2; 4 mg·m−3 | ROS increase in | [ |
| 21 days | 220–250 g | Male albino-Wistar rats | HgCl2 | 400; 800; 1600 µg·kg−1/day | Spatial memory impairments; hippocampal mitochondrial dysfunction | [ |
| 28 days | Adult | Male Wistar albino rats | HgCl2 | 1000 µg·kg−1/day | Histopathological changes in the lung tissue; OS | [ |
| 28 days | 49 days old | Male Wistar rats | MeHg | 0; 20; 200; 2000 µg·kg−1/day | Accumulation of the Amyloid Beta (Aβ) in the hippocampus | [ |
| 28 days | 250–300 g | Male Sprague-Dawley rats | HgCl2 | 1148 µg·kg−1/day | Fibrosis; asthma; OS | [ |
| 28 days | 42 days old | Male Sprague-Dawley rats | HgCl2 | 1000 µg·kg−1 | Necrosis; fibrosis | [ |
| 30 days | Adult | Female Wistar rats | HgCl2 | First dose | Presence of ovarian cystic follicles; ovarian OS; glucose/insulin intolerance | [ |
| 30 days | 56 days old | Male Wistar rats | HgCl2 | First dose | Anxiety; memory impairment | [ |
| 30 days | 56 days old | Male Wistar strain albino rats | HgCl2 | 1250 µg·kg−1 | Apoptosis by | [ |
| 45 days | Adult | Female Wistar albino rats | Hg vapour | 1 mg·m−3 | Loss of Purkinje cells; deleterious effects on the cerebellum structure | [ |
| 45 days | 90 days old | Male Wistar rats | HgCl2 | 375 µg·kg−1/day | Cognitive disorders; OS; cytotoxicity; apoptosis induction | [ |
| 45 days | 150 days old | Male Wistar rats | HgCl2 | 375 µg·kg−1/day | Short and long-term memory impairments; motor deficits; accumulation in hippocampus and cortex | [ |
| 45 days | 90 days old | Male Wistar rats | HgCl2 | 375 µg·kg−1/day | Motor disorders; cellular death; apoptosis; OS | [ |
| 7, 14, 28, 42, 56 days | 42 days old | Male C57BL/6NJcl mice | MeHg-gluta-thione 1:1 | 30,000 µg·kg−1 | Reduction of antioxidant enzyme expression | [ |
| 56 days | 42 days old | Male C57BL/6NJcl mice | MeHg | 30,000 µg·kg−1 | Neuronal degeneration | [ |
| 60 days | 90 days old | Wistar rats | MeHg | 40 µg·kg−1/day | Alveolar bone loss | [ |
Figure 2Mechanism of Hg toxicity and its effects at the cellular level.
Summary of several clinical studies with toxic and neurotoxic effects of Hg exposure in humans.
| Exposure Duration | Age of Exposure | Gender | Chemical | Concentration | Major Endpoints | Reference |
|---|---|---|---|---|---|---|
| 2 days | 40 years old | male | metallic Hg | 60 μg·L−1 | Schizophrenia and inflammatory soft tissue lesions | [ |
| 7 days | 36 years old | male | metallic Hg | 300 μg·L−1 | Abdominal pain, diarrhoea and fever | [ |
| 14 days | 20 years old | female | liquid Hg | 510 μg·L−1 | Fatigue and headache | [ |
| 14 days | 22 years old | female | liquid Hg | 129.9 μg·L−1 | Headache, gingival pain, and numbness in the arms and legs | [ |
| 14 days | 23 years old | female | liquid Hg | 430 μg·L−1 | Fatigue and headache | [ |
| 14 days | 29 years old | male | liquid Hg | 544 μg·L−1 | Headache, gingival pain, and numbness in the arms and legs | [ |
| 14 days | 54 years old | female | liquid Hg | 518 μg·L−1 | Fever, cough, night sweats, weight loss, and pain in the extremities | [ |
| 18 days | 36 years old | male | metallic Hg | 244 μg·L−1 | Rash, sore throat, fever, chills, cough and diarrhoea | [ |
| 26 days | 67 years old | male | metallic Hg | 1577 μg·L−1 | Severe pneumonitis, anuria | [ |
| 50 days | 30 years old | male | metallic Hg | 760 μg·L−1 | Weakness, malaise, excessive diaphoresis, coughing, fever, shortness of breath, diarrhoea, dysphasia, and polyuria | [ |
| 50 days | 53 years old | male | metallic Hg | 326 μg·L−1 | Persistent cough, dyspnoea and insomnia | [ |
| 60 days | 20 years old | male | metallic Hg | 635 μg·L−1 | Anorexia | [ |
| 2 years | 46 years old | female | metallic Hg | 1929 μg·L−1 | Severe pain, ischemia, erythematous lesions, cyanosis of the left hand | [ |
| 5 years | 33 years old | male | Hg vapour | 2.4 μg·L−1 | Colour vision deficiency | [ |
| 6 years | 37 years old | male | Hg vapour | 134.7 μg·L−1 | Colour vision deficiency | [ |
| 7 years | 42 years old | female | Hg vapour | 50 μg·L−1 | Colour vision deficiency | [ |
| 8.5 years | 36 years old | female | Hg vapour | 1.2 μg·L−1 | Colour vision deficiency | [ |
| 9 years | 34 years old | male | Hg vapour | 73.8 μg·L−1 | Colour vision deficiency | [ |
| 10 years | 43 years old | male | Hg vapour | 9 μg·L−1 | Colour vision deficiency | [ |
| 12 years | 43 years old | male | Hg vapour | 56.6 μg·L−1 | Colour vision deficiency | [ |
| 12 years | 43 years old | male | Hg vapour | 66 μg·L−1 | Colour vision deficiency | [ |
| 12 years | 45 years old | female | Hg vapour | 2 μg·L−1 | Colour vision deficiency | [ |
| 18 years | 36 years old | male | Hg vapour | 20 μg·L−1 | Colour vision deficiency | [ |
| not mentioned | 21 years old | male | metallic Hg | 11,000 μg·L−1 | Granuloma in the antecubital fossa | [ |
| not mentioned | 22 years old | male | metallic Hg | 3700 μg·L−1 | Arthro-myalgias, fever, weakness, chest pain (multiple punctuates metallic densities in radiographs) | [ |
Overview of the chemically synthesized and natural compounds used to minimize neurotoxicity of Hg, dating from 2010 to the present.
| Chemically Synthesized or Natural Compound | Hg Type | Experimental Model | Results | Reference |
|---|---|---|---|---|
| HgCl2 | Rats | Protected against the Hg-induced gross, oxidative, cerebral and cerebellar damage | [ | |
|
| HgCl2 | Rats | Mitigated the Hg-induced behavioural changes and alteration of the microanatomy of cerebral cortex, hippocampus and cerebellum | [ |
| HgCl2 | Rats | Protected against the Hg-induced degeneration of frontal cerebral cortical neurons | [ | |
| Curcumin | HgCl2 | Rats | Detoxification and antioxidant effects | [ |
| HgCl2 | Rats | Ameliorated the behavioural and biochemical alterations in the offspring | [ | |
| Diallyl sulphide (DAS) | HgCl2 | Rats | Counteracted the oxidative damage and increased the anti-inflammatory response against the Hg-induced neurotoxicity | [ |
|
| Dimethylmercury-(CH3)2Hg | Rats | Reduced the Hg levels in hippocampal homogenates and increased the activities of antioxidant enzymes | [ |
|
| MeHg (CH3Hg) | Rats | Protected against the Hg-induced OS | [ |
| Grape Seed Proanthocyanidin Extracts | CH3Hg | Rats | Counteracted the oxidative damage | [ |
| Vitamin K | CH3Hg | Primary cultured neurons from the cerebella of rat pups | Protected the neurons against Hg cytotoxicity | [ |
| Sodium selenite (Na2SeO3) | CH3Hg | Rats | Modulated the autophagic and apoptotic milieu of the cells via inhibiting the ROS-mediated apoptosis | [ |
| NAC | CH3Hg | Rats | Reduced the Hg-induced toxicity in the developing rat hippocampus | [ |